Gene expression of erythropoietin in hepatocellular carcinoma.
A 68-year-old man with hepatocellular carcinoma complicated by erythrocytosis showed an increased plasma level of immunoreactive erythropoietin (EPO). Northern blot analysis and RT-PCR (reverse transcriptase and polymerase chain reaction) of EPO mRNA extracted from a surgical specimen indicated high expression of EPO mRNA in the tumor tissue. Histological and immunocytochemical examination showed that the tumor was a hepatocellular carcinoma with predominant immunostaining for EPO. The erythrocytosis improved and the high serum EPO level decreased after resection of the tumor. This is the first demonstration of EPO mRNA expression in hepatocellular carcinoma tissue by RT-PCR.
Muta
H
H
Department of Gastroenterology, National Kyushu Cancer Center, Fukuoka.
Funakoshi
A
A
Baba
T
T
Uike
N
N
Wakasugi
H
H
Kozuru
M
M
Jimi
A
A
D000368:Aged; D001483:Base Sequence; D015152:Blotting, Northern; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D004921:Erythropoietin / Q000096:biosynthesis / Q000097:blood / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008969:Molecular Sequence Data; D011086:Polycythemia / Q000209:etiology*; D016133:Polymerase Chain Reaction; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; D004921:Erythropoietin